These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17885543)

  • 1. Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).
    Yui Y; Shinoda E; Kodama K; Hirayama A; Nonogi H; Haze K; Sumiyoshi T; Hosoda S; Kawai C;
    J Hypertens; 2007 Oct; 25(10):2019-26. PubMed ID: 17885543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.
    Yui Y; Sumiyoshi T; Kodama K; Hirayama A; Nonogi H; Kanmatsuse K; Origasa H; Iimura O; Ishii M; Saruta T; Arakawa K; Hosoda S; Kawai C;
    Hypertens Res; 2004 Mar; 27(3):181-91. PubMed ID: 15080377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis.
    Yui Y; Sumiyoshi T; Kodama K; Hirayama A; Nonogi H; Kanmatsuse K; Origasa H; Iimura O; Ishii M; Saruta T; Arakawa K; Hosoda S; Kawai C
    Hypertens Res; 2004 Jul; 27(7):449-56. PubMed ID: 15302980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).
    Shinoda E; Yui Y; Kodama K; Hirayama A; Nonogi H; Haze K; Sumiyoshi T; Hosoda S; Kawai C;
    Hypertension; 2005 Jun; 45(6):1153-8. PubMed ID: 15851624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [JMIC-B study and its sub-analyses: effect of nifedipine in Japanese hypertensive patients with coronary artery disease].
    Yui Y
    Drugs; 2006; 66 Spec No 1():25-7. PubMed ID: 18200776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.
    Yui Y; Kodama K; Hirayama A; Nishio R; Iwanaga Y; Nonogi H; Haze K; Sumiyoshi T; Yui N; Hosoda S; Kawai C;
    J Hypertens; 2010 Jan; 28(1):178-85. PubMed ID: 19927011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.
    Ikram H; Low CJ; Shirlaw TM; Foy SG; Crozier IG; Richards AM; Khurmi NS; Horsburgh RJ
    Br Heart J; 1994 Jan; 71(1):30-3. PubMed ID: 8297690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris.
    Boden WE; Korr KS; Bough EW
    JAMA; 1985 Feb; 253(8):1131-5. PubMed ID: 2857206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions.
    Lubsen J; Vokó Z; Poole-Wilson PA; Kirwan BA; de Brouwer S;
    J Clin Epidemiol; 2007 Jul; 60(7):720-6. PubMed ID: 17573988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiographic course of coronary atherosclerosis in angina pectoris. Its relation to 2 years' treatment with propranolol, nifedipine and nitrates].
    Loaldi A; Fabbiocchi F; Montorsi P; Guazzi M; Polese A; De Cesare N; Ravagnani P; Guazzi MD
    Cardiologia; 1989 Nov; 34(11):959-66. PubMed ID: 2631989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of nifedipine GITS in stable coronary artery disease: Further analysis of the "ACTION" database.
    Meredith PA; Elliott HL
    Adv Ther; 2010 May; 27(5):297-306. PubMed ID: 20490733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia.
    Hugenholtz PG; Michels HR; Serruys PW; Brower RW
    Am J Cardiol; 1981 Jan; 47(1):163-73. PubMed ID: 6969985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris.
    Blaustein AS; Heller GV; Kolman BS
    Am J Cardiol; 1983 Nov; 52(8):950-4. PubMed ID: 6139007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina.
    Elliott HL; Meredith PA
    J Hum Hypertens; 2011 Jan; 25(1):63-70. PubMed ID: 20182454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]).
    Hirayama A; Kodama K; Yui Y; Nonogi H; Sumiyoshi T; Origasa H; Hosoda S; Kawai C;
    Am J Cardiol; 2003 Oct; 92(7):789-93. PubMed ID: 14516877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action.
    Dietz R; Waas W; Süsselbeck T; Willenbrock R; Osterziel KJ
    Circulation; 1993 May; 87(5 Suppl):IV108-16. PubMed ID: 8485825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamics of critical stenosis in patients with unstable angina pectoris].
    Karsch KR; Niemczyk P; Voelker W; Seipel L
    Z Kardiol; 1984 Sep; 73(9):552-9. PubMed ID: 6438935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine and angina pectoris. Short-term changes in quantitative coronary angiography with nifedipine and clinical response to treatment in effort-induced, mixed, and spontaneous angina pectoris.
    De Cesare N; Bartorelli A; Fabbiocchi F; Loaldi A; Montorsi P; Polese A; Guazzi MD
    Chest; 1988 Mar; 93(3):485-92. PubMed ID: 3277802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.